Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degradation of Peptide YY
NCT02493959Phase 1Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of peptide YY in obesity, sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoints: PYY3-34 concentration and Half-lives of PYY1-36 and PYY3-36. Started May 2014; status: completed.
02
Drugs
peptide YY
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02493959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493959.